Terms: = Lung cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
76 results:
1. lung cancer outcomes in the elderly: potential disparity in screening.
Singh A; Mazzola E; Xie Y; Marshall MB; Jaklitsch MT; Wilder FG
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38445715
[TBL] [Abstract] [Full Text] [Related]
2. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
3. Pulmonary salivary gland tumor-hyalinizing clear cell carcinoma: a literature review.
Wang X; Hu S; Lu H
Diagn Pathol; 2024 Feb; 19(1):37. PubMed ID: 38389101
[TBL] [Abstract] [Full Text] [Related]
4. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract] [Full Text] [Related]
5. Clinical, Genomic, and Transcriptomic Featurses of lung Adenocarcinoma With Uncommon EGFR Mutation.
Hayasaka K; Takeda H; Sakurada A; Matsumura Y; Abe J; Shiono S; Notsuda H; Suzuki H; Endo M; Motohashi H; Okada Y
Clin Lung Cancer; 2024 Jan; 25(1):e43-e51. PubMed ID: 37985312
[TBL] [Abstract] [Full Text] [Related]
6. treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study.
Manninen O; Puuniemi L; Iivanainen S; Arffman M; Kaarteenaho R; Koivunen JP
Acta Oncol; 2023 Dec; 62(12):1854-1861. PubMed ID: 37934101
[TBL] [Abstract] [Full Text] [Related]
7. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract] [Full Text] [Related]
8. Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review.
Li Z; Li W; Xue L
Diagn Pathol; 2023 Aug; 18(1):90. PubMed ID: 37553667
[TBL] [Abstract] [Full Text] [Related]
9. atf1 promotes the malignancy of lung adenocarcinoma cells by transcriptionally regulating ZNF143 expression.
Mei J; Liu Y; Sheng Y; Liu Y; Chen L; Wang H; Cheng M; Zhai Z; Xu L
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):769-782. PubMed ID: 37158648
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of Brain Metastases Development in Patients With lung cancer by Explainable Artificial Intelligence From Electronic Health Records.
Li Z; Li R; Zhou Y; Rasmy L; Zhi D; Zhu P; Dono A; Jiang X; Xu H; Esquenazi Y; Zheng WJ
JCO Clin Cancer Inform; 2023 Apr; 7():e2200141. PubMed ID: 37018650
[TBL] [Abstract] [Full Text] [Related]
11. Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-lung 3 Part 2 Trial.
Makharadze T; Gogishvili M; Melkadze T; Baramidze A; Giorgadze D; Penkov K; Laktionov K; Nemsadze G; Nechaeva M; Rozhkova I; Kalinka E; Li S; Li Y; Kaul M; Quek RGW; Pouliot JF; Seebach F; Lowy I; Gullo G; Rietschel P
J Thorac Oncol; 2023 Jun; 18(6):755-768. PubMed ID: 37001859
[TBL] [Abstract] [Full Text] [Related]
12. A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.
Assaf ZJF; Zou W; Fine AD; Socinski MA; Young A; Lipson D; Freidin JF; Kennedy M; Polisecki E; Nishio M; Fabrizio D; Oxnard GR; Cummings C; Rode A; Reck M; Patil NS; Lee M; Shames DS; Schulze K
Nat Med; 2023 Apr; 29(4):859-868. PubMed ID: 36928816
[TBL] [Abstract] [Full Text] [Related]
13. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.
Bylicki O; Tomasini P; Radj G; Guisier F; Monnet I; Ricordel C; Bigay-Game L; Geier M; Chouaid C; Daniel C; Swalduz A; Toffart AC; Doubre H; Peloni JM; Moreau D; Subtil F; Grellard JM; Castera M; Clarisse B; Martins-Lavinas PH; Decroisette C; Greillier L;
Eur J Cancer; 2023 Apr; 183():38-48. PubMed ID: 36801605
[TBL] [Abstract] [Full Text] [Related]
14. A markerless beam's eye view motion monitoring algorithm based on structure conversion and demons registration in medical image with partial data.
Qiu M; Guan Q; Zhong J; Huang T; Luo N; Deng Y
Med Phys; 2023 Jul; 50(7):4415-4429. PubMed ID: 36705235
[TBL] [Abstract] [Full Text] [Related]
15. Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.
Gogishvili M; Melkadze T; Makharadze T; Giorgadze D; Dvorkin M; Penkov K; Laktionov K; Nemsadze G; Nechaeva M; Rozhkova I; Kalinka E; Gessner C; Moreno-Jaime B; Passalacqua R; Li S; McGuire K; Kaul M; Paccaly A; Quek RGW; Gao B; Seebach F; Weinreich DM; Yancopoulos GD; Lowy I; Gullo G; Rietschel P
Nat Med; 2022 Nov; 28(11):2374-2380. PubMed ID: 36008722
[TBL] [Abstract] [Full Text] [Related]
16. Ranking the most influential predictors of CT-based radiomics feature values in metastatic lung adenocarcinoma.
Crombé A; Lafon M; Nougaret S; Kind M; Cousin S
Eur J Radiol; 2022 Oct; 155():110472. PubMed ID: 35985090
[TBL] [Abstract] [Full Text] [Related]
17. Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.
Wurstbauer K; Kazil M; Meinschad M; Pinter R; De Vries C; Clemens P; Kreuter C; Hernler T; Hitzl W; Cerkl P; Künzler T; De Vries A
Radiat Oncol; 2022 Jul; 17(1):120. PubMed ID: 35799182
[TBL] [Abstract] [Full Text] [Related]
18. Years of life lost to cancer among the United States HIV population, 2006-2015.
Luo Q; Pfeiffer RM; Noone AM; Horner MJ; Engels EA; Shiels MS
AIDS; 2022 Jul; 36(9):1279-1286. PubMed ID: 35608110
[TBL] [Abstract] [Full Text] [Related]
19. Effect of Pulmonary Functions on Survival in Patients with Operable Non-small Cell lung cancer.
Cihanbeylerden M; Yumrukuz M; Kurt B; Tuccar C; Safak C
J Coll Physicians Surg Pak; 2022 May; 32(5):606-612. PubMed ID: 35546696
[TBL] [Abstract] [Full Text] [Related]
20. Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery.
Rabinel P; Vergé R; Cazaux M; Mazzoni L; Renaud C; Rouch A; Brouchet L
Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35147671
[TBL] [Abstract] [Full Text] [Related]
[Next]
